8 Results for "

Stargardt disease

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Stargardt disease" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P76196
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PROM1; AC133 Antigen; Prev. PROML1; Prominin-1; Prev. STGD4; Stargardt disease 4 (Autosomal Dominant); Prev. MCDR2; Hematopoietic Stem Cell Antigen; CORD12; Macular Dystrophy, Retinal 2; CD133; Prominin (Mouse)-Like 1; AC133; CD133 Isoform H; RP41; CD133
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-123623
CAS No.: 1821327-95-0
Purity:  98.01%
Synonyms: LBS-008; BPN-14967
Target:  

Lipocalin Family

Research Areas:  

Others

Tinlarebant (LBS-008) is an orally active non-retinoid RBP4 (retinol-binding protein 4) antagonist. Tinlarebant can be used for the research of the Stargardt disease .
loading...
    loading...
Cat. No.: HY-175663
Target:  

RPE65

Research Areas:  

Metabolic Disease

EYE-002 is a RPE65 inhibitor with an IC50 of 69 nM. EYE-002 promotes recovery of scotopic ERG a-/b-wave amplitudes. EYE-002 regulates the visual cycle in mice by reducing 11-cis-retinal (11cRAL) (HY-116711) synthesis and increasing all-trans-retinyl esters (atREs). EYE-002 exerts protective effects against photic retinal damage in mice. EYE-002 can be used for the study of visual cycle-associated retinopathies, such as Stargardt disease type 1 (STGD1) .
loading...
    loading...
Cat. No.: HY-175664
Target:  

RPE65

Research Areas:  

Metabolic Disease

EYE-003 is an orally active RPE65 inhibitor with an IC50 of 102 nM. EYE-003 regulates the visual cycle in mice by reducing 11-cis-retinal (11cRAL) (HY-116711) synthesis and increasing all-trans-retinyl esters (atREs). EYE-003 suppresses scotopic ERG b-wave amplitude and exerts protective effects against retinal degeneration in Abca4 ⁻/⁻ Rdh8 ⁻/⁻ mice (a STGD1 model) by reducing retinal autofluorescent puncta and preserving outer nuclear layer (ONL) thickness in a dose-dependent manner. EYE-003 can be used for the study of visual cycle-associated retinopathies, such as Stargardt disease type 1 (STGD1) .
loading...
    loading...
Cat. No.: HY-187175
CAS No.: 2172940-88-2
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Rp-8-Br-pME-PET-cGMPS is a cGMP (HY-113469) analog. Rp-8-Br-pME-PET-cGMPS is used for research on retinal dystrophy, retinitis pigmentosa, Stargardt disease, and macular degeneration .
loading...
    loading...
Cat. No.: HY-182385
CAS No.: 1628945-93-6
Target:  

Lipocalin Family

Research Areas:  

Metabolic Disease

BPN-14136 is an orally effective retinol-binding protein 4 (RBP4) inhibitor. BPN-14136 inhibits the binding of retinol to RBP4 with an IC50 of 12.8 nM. BPN-14136 inhibits retinol-dependent RBP4-transthyretin interaction (IC50 = 43.6 nM) and reduces circulating plasma RBP4 levels in vivo. BPN-14136 decreases the formation of cytotoxic bisretinoids in retinal pigment epithelial cells. BPN-14136 can be used for the research of atrophic age-related macular degeneration and Stargardt disease .
loading...
    loading...
Cat. No.: HY-P76197
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PROM1; AC133 Antigen; Prev. PROML1; Prominin-1; Prev. STGD4; Stargardt disease 4 (Autosomal Dominant); Prev. MCDR2; Hematopoietic Stem Cell Antigen; CORD12; Macular Dystrophy, Retinal 2; CD133; Prominin (Mouse)-Like 1; AC133; CD133 Isoform H; RP41; CD133
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P78732
Purity:  Purity analysis by SDS-PAGE is not available for VLP proteins.
Synonyms: PROM1; AC133 Antigen; Prev. PROML1; Prominin-1; Prev. STGD4; Stargardt disease 4 (Autosomal Dominant); Prev. MCDR2; Hematopoietic Stem Cell Antigen; CORD12; Macular Dystrophy, Retinal 2; CD133; Prominin (Mouse)-Like 1; AC133; CD133 Isoform H; RP41; CD133
Species:  
Human
Source:  
HEK293
loading...
    loading...